Inhibtion der Ca2+/Calmodulin-abhängigen Proteinkinase (CaMKII) verbessert die Kontratilität von terminal insuffizientem Myokard des Menschen
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details